Charles Craddock

39PUBLICATIONS
194CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyJapanese languageSolid tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|May 22, 2026
Initial leukemic epigenomic state determines hypomethylating agent response.

|Dec 04, 2025
Frequency and impact of somatic co-occurring mutations on post-transplant outcomes in acute myeloid leukemia: a multicenter registry analysis on behalf of the EBMT ALWP.

Ali Bazarbachi, Jacques-Emmanuel Galimard, Iman Abou Dalle

|Jul 15, 2025
Guidance for <i>JCO</i> Authors on Subgroup Representation and Reporting.

Stephanie B Wheeler, Alexia Iasonos, Iona Cheng

|May 22, 2025
Early-Phase Trials in <i>Journal of Clinical Oncology</i>.

Thomas E Stinchcombe, Gini F Fleming, Charles Craddock

|May 22, 2025
A revised prognostic model for patients with acute myeloid leukemia and first relapse.

Niek G van der Maas, Dimitri Breems, Clara P W Klerk

|May 21, 2025
Venetoclax-based non-intensive combinations for relapsed/refractory acute myeloid leukaemia-Real-world data from a UK-wide programme.

Henry Wood, Jenny O'Nions, Wei Yee Chan

Pageof 7

Frequent Collaborators

10 joint publications

Mohamad Mohty

9 joint publications

Arnon Nagler

8 joint publications

Myriam Labopin

7 joint publications

Fabio Ciceri